Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)
Journal
Advances in Therapy
Journal Volume
42
Journal Issue
1
Start Page
144-145
ISSN
0741-238X
1865-8652
Date Issued
2024-12-05
Author(s)
Publisher
Springer Science and Business Media LLC
Type
other